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Aims: Cerebellar ataxia is commonly observed in hyperornithinemia-hyperammonemia-homocitrullinuria
(HHH) syndrome, an inherited metabolic disorder biochemically characterized by ornithine (Orn),
homocitrulline (Hcit) and ammonia accumulation. Since the pathophysiology of cerebellum damage in this
disorder is still unknown, we investigated the effects of Hcit and Orn on important parameters of redox
and energy homeostasis in cerebellum of young rats.
Material and methods: We determined thiobarbituric acid-reactive substance (TBA-RS) levels, carbonyl con-
tent, nitrate and nitrite production, hydrogen peroxide production, GSH concentrations, sulfhydryl content,
as well as activities of respiratory chain complexes I–IV, creatine kinase, Na+,K+-ATPase, aconitase and
α-ketoglutarate dehydrogenase.
Key ﬁndings: Orn and Hcit signiﬁcantly increased TBA-RS levels (lipid oxidation), that was totally prevented
by melatonin and reduced glutathione (GSH). We also found that nitrate and nitrite production was not al-
tered by any of the metabolites, in contrast to hydrogen peroxide production which was signiﬁcantly en-
hanced by Hcit. Furthermore, GSH concentrations were signiﬁcantly reduced by Orn and Hcit and
sulfhydryl content by Orn, implying an impairment of antioxidant defenses. As regards energy metabolism,
Orn and Hcit provoked a signiﬁcant reduction of aconitase activity, without altering the other parameters.
Furthermore, Orn-elicited reduction of aconitase activity was totally prevented by GSH, indicating that the
critical groups of this enzyme were susceptible to oxidation caused by this amino acid.
Signiﬁcance: Taken together, our data indicate that redox homeostasis is disturbed by the major metabolites
accumulating in HHH syndrome and that this mechanism may be implicated in the ataxia and cerebellar ab-
normalities observed in this disorder.© 2013 Published by Elsevier Inc.Introduction
The hyperornithinemia-hyperammonemia-homocitrullinuria (HHH)
syndrome (MIM#238970) is an inherited disorder caused by a defect in
the transport of ornithine (Orn) into the mitochondrial matrix due to
mutations in the SLC25A15 gene, encoding the ornithine translocase 1
transporter previously termed ORNT1 also named ORC1 (Camacho et
al., 1999; Fiermonte et al., 2003; Kim et al., 2012). The inability to import
Orn from the cytosol into the mitochondria results in intramito-
chondrial Orn deﬁciency and a functional impairment of the urea
cycle at the level of ornithine transcarbamoylase, with consequent
hyperammonemia. Because the normal pathway for Orn catabolism
proceeds via the intramitochondrial enzyme ornithine aminotransferase,, Instituto de Ciências Básicas da
iro Barcelos No 2600 — Anexo,
5571; fax: +55 51 3308 5535.
sevier Inc.cytosolic Orn accumulates resulting in hyperornithinemia. In the absence
of intramitochondrial Orn, accumulating carbamoyl phosphate either
condenses with lysine to form homocitrulline (Hcit), leading to
homocitrullinuria, or is shunted through the cytosolic pyrimidine biosyn-
thetic pathway leading to increased excretion of orotic acid and uracil in
the urine (Korman et al., 2004).
HHH syndrome is clinically characterized by acute intermittent
episodes of hyperammonemia accompanied by ataxia, vomiting, leth-
argy, and confusion. Besides cerebellar signs, patients also present
movement disorders, dystonia, epilepsy, liver dysfunction and aver-
sion to protein (Palmieri, 2008; Valle and Simell, 2001; Miyamoto et
al., 2002; Kim et al., 2012; Filosto et al., 2012).
The central nervous system (CNS) pathology consists of demye-
linization, atrophy and stroke-like lesions in the cerebral cortex and cere-
bellum, which have been ascribed to the toxic effects of ammonia and
glutamine on the astrocyte, including changes in cellular bioenergetics, mi-
tochondrial dysfunction, osmotic swelling, and alterations in glutamine–
glutamate cycling (Gropman and Batshaw, 2004; Gropman, 2010;
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ever, it is unlikely that hyperammonemia is solely responsible for the path-
ophysiology of HHH syndrome since affected individuals who are
diagnosed early andmaintain goodmetabolic control (normal plasma am-
monia levels) nonetheless develop progressive neurologic dysfunction
years after their initial diagnosis. Therefore, chronic accumulation of Orn,
HCit, orotic acid (Oro) and other metabolic factors cannot be ruled out as
the contributing causes of the neurological symptoms seen in patients af-
fected by HHH syndrome and investigation of the role of these accumulat-
ing metabolites on the CNS function will eventually lead to a better
understandingof the relationshipbetween the clinical features and thebio-
chemical abnormalities of this disorder. In this context, recent studies re-
vealed that Orn and Hcit disrupt mitochondrial homeostasis in vitro and
in vivo in rat cerebral cortex (Amaral et al., 2009; Viegas et al., 2009, 2011).
It is of note that cerebellar ataxia and abnormalities are common
ﬁndings in HHH syndrome, although the pathogenesis of the cerebel-
lar damage in patients affected by this disorder is practically un-
known. Therefore, in the present study we investigated the effects
of Hcit and Orn on important biochemical parameters of oxidative
stress and energy metabolism in cerebellum of young rats. We deter-
mined thiobarbituric acid-reactive substances (TBA-RS) (lipid perox-
idation), carbonyl formation (protein oxidative damage), nitrate and
nitrite formation (reactive nitrogen species) and hydrogen peroxide
production (reactive oxygen species), reduced glutathione (GSH)
concentrations and sulfhydryl content (non-enzymatic antioxidant
defenses), as well as the activities of complexes I to IV (oxidative
phosphorylation), aconitase and α-ketoglutarate dehydrogenase
(citric acid cycle functioning), creatine kinase (intracellular energy
transfer) and Na+,K+-ATPase (neurotransmission).
Experimental procedures
Animal and reagents
We used 30-day-old Wistar rats obtained from the Central Animal
House of the Department of Biochemistry, ICBS, UFRGS. The animals
had free access to water and to a standard commercial chow and were
maintained on a 12:12 h light/dark cycle in an air-conditioned constant
temperature (22 ± 1 °C) colony room. The “Principles of Laboratory
Animal Care” (NIH publication no. 80–23, revised 1996) were followed
in all experiments and the experimental protocol was approved by the
Ethics Committee for Animal Research of the Federal University of Rio
Grande do Sul, Porto Alegre, Brazil. All efforts were made to minimize
the number of animals used and their suffering.
All chemicals were purchased from Sigma Chemical Co., St. Louis,
MO, USA. Hcit and Orn were dissolved on the day of the experiments
in the buffer used for each assay to ﬁnal concentrations in the incuba-
tion medium ranging from 0.1 to 5 mM, and the pH adjusted to 7.4.
Ethical statement
This study was performed in strict accordance with the EU Directive
2010/63/EU for Animal Experiments and approved by the Ethical Com-
mittee for the Care and Use of Laboratory Animals of HCPA. All efforts
were alsomade to use theminimal number of animals necessary to pro-
duce reliable scientiﬁc data and to minimize the animal discomfort.
Preparation of cerebellum samples and incubation
Ratswere sacriﬁced by decapitationwithout anesthesia, and the cer-
ebellumwas dissected, weighed and homogenized in 10 volumes (w/v)
of 20 mM sodium phosphate buffer, pH 7.4, containing 140 mM KCl.
Homogenates were centrifuged at 750 g for 10 min at 4 °C to discard
nuclei and cell debris (Evelson et al., 2001). The pellet was discarded
and the supernatant, a suspension of mixed and preserved organelles,
including mitochondria, was separated and pre-incubated for 1 h at37 °C with Hcit or Orn. Controls did not contain these metabolites in
the incubation medium. Immediately after pre-incubation, aliquots
were taken to measure the oxidative stress parameters TBA-RS,
carbonyl formation, sulfhydryl content, GSH levels, nitrate and nitrite
production. In some experiments, antioxidants were co-incubated with
supernatants at the following ﬁnal concentrations: 1000 μM reduced
glutathione (GSH), 1000 μMmelatonin (MEL), 7.5 μM Trolox (TRO, sol-
uble α-tocoferol), 500 μM Nω-nitro-L-arginine methyl ester (L-NAME)
and 100 μM lipoic acid (LA). The doses of antioxidants used in the
present study were selected according to the literature and to previous
experiments demonstrating that these doses are capable of preventing
oxidative damage and do not alter per se on the biochemical parameters
analyzed (Leipnitz et al., 2008; Ribeiro et al., 2011; Moura et al., 2012;
Tonin et al., 2012).
For the determination of the activities of the respiratory chain com-
plexes I–III, II, II–III and IV, the cerebellumwashomogenized (1:20,w/v)
in SETH buffer (250 mM sucrose, 2.0 mM EDTA, 10 mM Trizma base
and 50 UI·mL−1 heparin), pH 7.4. The homogenates were centrifuged
at 800 g for 10 min and the supernatants were kept at −70 °C until
being used for enzyme activity determination. For the measurement of
hydrogen peroxide (H2O2) release and the activities of aconitase and
α-ketoglutarate dehydrogenase, mitochondrial fractions from cerebel-
lum were prepared according to Rosenthal et al. (1987). For creatine
kinase activity determination, the cerebellum was homogenized
(1:10 w/v) in isosmotic saline solution and he homogenates used in
the assay. For Na+,K+-ATPase activity, synaptic plasma membranes
were prepared according to the method of Jones and Matus (1974).
The cerebellum was homogenized in 10 volumes of 0.32 mM sucrose
solution containing 5.0 mM HEPES and 1.0 mM EDTA. Then, the ho-
mogenates were added to a discontinuous sucrose density gradient
consisting of successive layers of 0.3, 0.8 and 1.0 mM. After centrifuga-
tion at 69,000 g for 2 h, the fraction at the 0.8–1.0 mMsucrose interface
was taken as the membrane enzyme preparation. These samples were
pre-incubated for 30 min at 37 °C with Hcit or Orn. Controls did not
contain these metabolites in the incubation medium.
We always performed the experiments using blanks in order to
detect artifacts and validate our methodology. Whereas controls
contained tissue preparations but not Orn and Hcit, some blanks
were devoid of cerebellum preparations in the incubation medium
supplemented by Orn or Hcit and served to detect interferences of
the tested metabolites on the techniques utilized to measure the ox-
idative stress and bioenergetics parameters (results not shown).
Thiobarbituric acid-reactive substances (TBA-RS)
TBA-RS was determined according to the method of Esterbauer
and Cheeseman (1990). Brieﬂy, 300 μL of cold 10% trichloroacetic
acid were added to 150 μL of pre-incubated cerebellum supernatants
and centrifuged at 3000 g for 10 min. Three hundred microliters of
the pre-incubated supernatants (containing approximately 0.3 mg
of protein) were transferred to a pyrex tube and incubated with
300 μL of 0.67% TBA in 7.1% sodium sulphate on a boiling water
bath for 25 min. The tubes containing the mixture were allowed to
cool on running tap water for 5 min. The resulting pink-stained
TBA-RS was determined in a spectrophotometer at 532 nm. A calibra-
tion curve was performed using 1,1,3,3-tetramethoxypropane, and
each curve point was subjected to the same treatment as superna-
tants. TBA-RS values were calculated as nmol/ mg protein.
Protein carbonyl content
Protein carbonyl formation, a marker of protein oxidative damage,
was measured spectrophotometrically according to Reznick and
Packer (1994). Two hundred microliters of the aliquots from the
pre-treated supernatants (containing approximately 0.3 mg of pro-
tein) were treated with 400 μL of 10 mM 2,4-dinitrophenylhidrazine
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the dark for 1 h. Samples were then precipitated with 600 μL 20% tri-
chloroacetic acid and centrifuged for 5 min at 9000 g. The pellet was
then washed with 1 mL ethanol:ethyl acetate (1:1, v/v) and dissolved
in 550 μL 6 M guanidine prepared in 2.5 N HCl at 37 °C for 5 min. The
difference between the DNPH-treated and HCl-treated samples
(blank) was used to calculate the carbonyl content determined at
365 nm. The results were calculated as nmol of carbonyl groups/mg
of protein, using the extinction coefﬁcient of 22,000 × 106 nmol/mL
for aliphatic hydrazones.Nitrate and nitrite formation
Nitrate and nitrite production was measured according to Miranda
et al. (2001). Two hundred microliters of vanadium chloride was
added to the tube containing 200 μL of pre-treated supernatants
(0.3 mg of protein) for complete reduction of nitrate to nitrite. Then,
200 μL of Griess reagent (a mixture of N-1-naphtylethylenediamine
dihydrochloride and sulfanilamide)were added, and the tubewas incu-
bated for 30 min at 37 °C in a water bath in a dark room. The resulting
pink-stained pigment was determined in a spectrophotometer at
540 nm. A calibration curve was performed using sodium nitrate
(2.5–100 μM), and each curve point was subjected to the same treat-
ment as supernatants. Nitrate and nitrite formation values were calcu-
lated as nmol/mg protein.Mitochondrial hydrogen peroxide (H2O2) release
Mitochondrial preparations (0.2 mg protein·mL−1) supported by
5 mM glutamate and 5 mM malate as substrates were incubated in
standard reaction medium in the presence of 10 μM Amplex red
and 1 U/mL horseradish peroxidase. The ﬂuorescence was monitored
during 500 s on a Hitachi F-4500 spectroﬂuorometer operated at ex-
citation and emission wavelengths of 563 and 587 nm, respectively,
and slit widths of 5 nm. Antimycin A (0.1 μg/mL−1) was added at
the end of the measurements (Mohanty et al., 1997). Data were
expressed as FAU.Reduced glutathione (GSH) concentrations
GSH concentrations were measured according to Browne and
Armstrong (1998). One volume of metaphosphoric acid was added
to the pre-treated samples, which were centrifuged for 10 min at
7000 g. Then, 185 μL of 100 mM sodium phosphate buffer, pH 8.0,
containing 5 mM EDTA, and 15 μL of o-phthaldialdehyde (1 mg/mL)
were added to 30 μL of cerebellum supernatants (0.3–0.5 mg of pro-
tein). This mixture was incubated at room temperature in a dark
room for 15 min. Fluorescence was measured using excitation and
emission wavelengths of 350 nm and 420 nm, respectively. Calibra-
tion curve was prepared with standard GSH (0.001–1 mM) and the
concentrations were calculated as nmol/mg protein.Sulfhydryl content
This assay is based on the reduction of 5,5′-dithio-bis(2-
nitrobenzoic acid) (DTNB) by thiols, generating a yellow derivative
(TNB) whose absorption is measured spectrophotometrically at
412 nm (Aksenov and Markesbery, 2001). Brieﬂy, 30 μL of 10 mM
DTNB was added to an aliquot of 50 μL of pre-treated supernatants.
This was followed by 30 min incubation at room temperature in a
dark room. The sulfhydryl content is inversely correlated to oxidative
damage to proteins. Results were calculated as nmol TNB/mg protein.Determination of the respiratory chain complexes activities
Mitochondrial respiratory chain enzyme activities (complexes I–
III, II, II–III and IV) were measured in the supernatants with a protein
concentration varying from 1.5 to 4.0 mg protein/mL. The activity of
NADH:cytochrome c oxidoreductase (complexes I–III) was assessed
as described by Schapira et al. (1990). The activities of succinate:
DCIP-oxidoreductase (complex II) and succinate:cytochrome c oxidore-
ductase (complexes II–III) were determined according to the method of
Fischer et al. (1985) and of cytochrome c oxidase (complex IV) according
to Rustin et al. (1994). The methods described to measure these
activities were slightly modiﬁed, as described in details in a previous
report (da Silva et al., 2002). The activities of the respiratory chain
complexes were calculated as nmol/ min/ mg protein.
Activities of aconitase and α-ketoglutarate dehydrogenase complex
The activity of the enzyme aconitase was measured according to
Morrison (1954), following the reduction of NADP+ at wavelengths
of excitation and emission of 340 and 466 nm, respectively. The activ-
ity of α-ketoglutarate dehydrogenase complex was evaluated accord-
ing to Lai and Cooper (1986) and Tretter and Adam-Vizi (2004), with
modiﬁcations. The incubation medium contained 50 mM K2PO4,
1 mM MgCl2, 0.2 mM thiamine pyrophosphate, 0.3 mM DTT,
100 μM EGTA, 50 μM coenzyme A-SH, 250 μM α-ketoglutarate and
2 mM NAD+, pH adjusted to 7.35. The reduction of NAD+ was
recorded in a Hitachi F-4500 spectroﬂuorometer at wavelengths of
excitation and emission of 340 e 466 nm, respectively.
Determination of creatine kinase activity
Creatine kinase activity was measured in the supernatants
containing 0.4–1.2 μg of protein in a reaction mixture consisting of
60 mM Tris–HCl, pH 7.5, 7 mM phosphocreatine, 9 mM MgSO4 and
0.625 mM lauryl maltoside in a ﬁnal volume of 100 μL. After 10 min
of pre-incubation at 37 °C, the reaction was started by the addition
of 0.3 μmol of ADP. The reaction was stopped after 10 min by the ad-
dition of 1 μmol of p-hydroxymercuribenzoic acid. The creatine
formed was estimated according to the colorimetric method of
Hughes (1962) with slight modiﬁcations (Schuck et al., 2002). The
color was developed by the addition of 100 μL of 2% α-naphthol and
100 μL of 0.05% diacetyl in a ﬁnal volume of 1 mL and read
spectrophotometrically at 540 nm after 20 min. Results were
calculated as μmol creatine/min/mg protein.
Determination of Na+,K+-ATPase activity
The reaction mixture for the Na+,K+-ATPase assay consisted of
5 mM MgCl2, 80 mM NaCl, 20 mM KCl, 40 mM Tris–HCl buffer,
pH 7.4, and puriﬁed synaptic membranes containing approximately
3 μg of protein in a ﬁnal volume of 200 μL. The enzymatic assay oc-
curred at 37 °C during 5 min and started by the addition of ATP
(disodium salt, vanadium free) to a ﬁnal concentration of 3 mM. The re-
actionwas stopped by the addition of 200 μL of 10% trichloroacetic acid.
Mg2+-ATPase ouabain-insensitive was assayed under the same condi-
tions with the addition of 1 mM ouabain. Na+,K+-ATPase activity was
calculated by the difference between the two assays (Tsakiris and
Deliconstantinos, 1984). Released inorganic phosphate (Pi) was mea-
sured by the method of Chan et al. (1986). Enzyme speciﬁc activity
was calculated as nmol Pi released/min/mg protein.
Protein determination
Protein content was determined in cerebral cortex supernatants
by the method of Lowry et al. (1951), using bovine serum albumin
as a standard.
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Unless otherwise stated, results are presented as mean ± stan-
dard deviation. Assays were performed in duplicate or triplicate and
the mean or median was used for statistical analysis. Data was ana-
lyzed using one-way analysis of variance (ANOVA) followed by the
post-hoc Duncanmultiple range test when F was signiﬁcant. Only sig-
niﬁcant F values are shown in the text. Differences between groups
were rated signiﬁcant at P b 0.05. All analyses were carried out in
an IBM-compatible PC computer using the Statistical Package for the
Social Sciences (SPSS) software.Results
Orn and Hcit induce lipid peroxidation in rat cerebellum probably
through reactive oxygen species formation
First, we investigated the in vitro effects of Orn and Hcit on TBA-RS
levels in cerebellum of young rats. Fig. 1 shows that Orn [A: F(4,24) =
30.998; P b 0.001] and Hcit [B:F(4,29) = 8.897; P b 0.001] signiﬁcantly
increased TBA-RS levels in a dose-dependent manner [Orn: β =0.919;
P b 0.001; Hcit:β = 0.761; P b 0.001], indicating that thesemetabolites
induce lipid peroxidation.We then evaluated the role of antioxidants on
Orn-induced lipid oxidative damage. Cerebellar supernatants were
co-incubated with 5.0 mM Orn and each of the antioxidants GSH
(1500 μM), MEL (1000 μM), TRO (7.5 μM), L-NAME (500 μM) or
LA (100 μM). Our results show that MEL [F(7,47) = 33.249;
P b 0.001] and GSH [F(5,35) = 83.773; P b 0.001] were able to
fully prevent Orn-induced TBA-RS levels increase, in contrast to
TRO, L-NAME and LA, which did not alter Orn-induced lipid perox-
idation (Fig. 4).Orn and Hcit do not alter carbonyl formation in rat cerebellum
The next set of experiments was carried out to evaluate the in
vitro effects of Orn and Hcit on carbonyl formation. We observed
that neither Orn (control: 2.47 ± 0.89; 5 mM Orn: 2.69 ± 0.57;
n = 6) nor Hcit (control: 4.24 ± 0.50; 5 mM Hcit: 4.65 ± 0.79;
n = 6) signiﬁcantly altered this parameter.Orn and Hcit do not induce nitrate and nitrite production in rat cerebellum
We also assessed the effect of Orn and Hcit on nitrate and nitrite
formation. These metabolites did not induce reactive nitrogen species
generation in cerebellum (control: 1.51 ± 0.65; 5 mM Orn: 1.44 ±
0.51; 5 mM Hcit: 1.45 ± 0.58; n = 6).Fig. 1. Effect of ornithine (Orn) (A) and homocitrulline (Hcit) (B) on thiobarbituric acid-reac
six independent experiments performed in triplicate and expressed as nmol/mg protein. *POrn and Hcit provoke a reduction of non-enzymatic antioxidant defenses
in rat cerebellum
The non-enzymatic antioxidant defenses were also assessed by in-
vestigating the effects of Orn and Hcit on GSH concentrations and sulf-
hydryl content in the cerebellum. We observed that Orn [F(4,28) =
42.691; P b 0.001] and Hcit [F(4,28) = 4.932; P b 0.05] signiﬁcantly de-
creased GSH concentrations in a dose-dependent fashion [Orn:
β = −0.662, P b 0.001; Hcit: β = −0.662; P b 0.001] (Fig. 2A). Fur-
thermore, Orn decreased sulfhydryl content [F(4,29) = 3.013; P b 0.05]
in a dose-dependent manner [β = −0.552; P b 0.01], in contrast to
Hcit that did not alter this parameter (Fig. 2B).
Hcit increases hydrogen peroxide production in rat cerebellum
Next, we evaluated whether Orn or Hcit were able to alter the hy-
drogen peroxide (H2O2) production in the presence of glutamate and
malate as substrates. We found that only Hcit signiﬁcantly increased
H2O2 production (Fig. 3).
The respiratory chain complexes I–IV activities are not altered by Orn
and Hcit in rat cerebellum
Wealso tested the inﬂuence of Orn andHcit on the activities of com-
plexes I–III, II, II–III and IV of the respiratory chain. We veriﬁed that
these activities were not altered by these metabolites (Table 1).
Orn and Hcit signiﬁcantly inhibit aconitase activity in rat cerebellum
The effects of Orn and Hcit on α-ketoglutarate dehydrogenase and
aconitase activities were also tested in mitochondrial preparations
from cerebellum. We observed that these compounds did not change
α-ketoglutarate dehydrogenase activity (control: 23.9 ± 5.27; 5 mM
Orn: 26 ± 9.23; 5 mM Hcit: 21.2 ± 8.87; n = 6). However, Orn
[F(4,15) = 5.667; P b 0.01] andHcit [F(4,16) = 5.667; P b 0.05]markedly
diminished aconitase activity in a dose-dependent manner [Orn:
β = −0.819; P b 0.001; Hcit: β = −0.697; P b 0.01] (Fig. 5A). We
then evaluated the role of antioxidants on Orn-induced aconitase activ-
ity inhibition. Cerebellar mitochondria were co-incubated with 5.0 mM
Orn and GSH (1500 μM), MEL (1000 μM) or TRO (7.5 μM). Our results
show that GSH [F(4,27) = 3.279; P b 0.05] was able to fully prevent
Orn-induced aconitase activity decrease, whereas MEL and TRO did
not alter this effect (Fig. 5B).
Orn and Hcit do not change creatine kinase and synaptic membrane
Na+, K+-ATPase activities in rat cerebellum
We also veriﬁed that Orn and Hcit did not altered the activities of
creatine kinase (control: 6.13 ± 1.11; 5 mM Orn: 7.7 ± 0.22; n = 6)tive substances (TBA-RS) in rat cerebellum. Values are means ± standard deviation for
b 0.05, ***P b 0.001, compared to controls (Duncan multiple range test).
Fig. 2. Effect of ornithine (Orn) and homocitrulline (Hcit) on reduced glutathione (GSH) concentrations (A) and sulfhydryl content (B) in rat cerebellum. Values are means ± stan-
dard deviation for six independent experiments performed in triplicate and expressed as nmol/mg protein. *P b 0.05, ***P b 0.001, compared to controls (Duncan multiple range
test).
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membrane Na+, K+-ATPase (control: 804 ± 127; 5 mM Orn:
816 ± 57; n = 6) (control: 892 ± 225; 5 mM Hcit: 648 ± 374;
n = 6).Fig. 3. Effect of ornithine (Orn) (A) and homocitrulline (Hcit) (B) on hydrogen perox-
ide production using 2.5 mM glutamate plus 2.5 mM malate as substrates in mito-
chondrial preparations from rat cerebellum. Antimycin (AA) (0.1 μg/mL) was added
at the end of assays, as indicated. Traces are representative of four independent exper-
iments and are expressed as ﬂuorescence arbitrary units (FAU).Discussion
Ataxia and cerebellar atrophy are observed inHHHsyndrome (Tsujino
et al., 2000; Miyamoto et al., 2002; Korman et al., 2004; Filosto et al.,
2012). Although the pathogenesis of the cerebellumdamage is practically
unknown, the CNS cellular pathophysiology in this disorder has been
generally attributed to the toxic effects of ammonia (Braissant, 2010;
Sofroniew and Vinters, 2010). However, it is unlikely that hyperammo-
nemia is solely responsible for the pathophysiology of HHH syndrome
since affected individuals who are diagnosed early and maintain good
metabolic control (normal plasma ammonia levels) nonetheless develop
progressive neurologic dysfunction. Therefore, it is conceivable that the
other metabolites accumulating in HHH syndrome, i.e., Orn and Hcit,
may be neurotoxic.
Therefore, we investigated the role of Orn and Hcit on important
parameters of oxidative stress and energy homeostasis in rat cerebel-
lum. We initially veriﬁed that Orn and Hcit signiﬁcantly increased
TBA-RS levels, reﬂecting an induction of malondialdehyde generation,
an end product of membrane fatty acid peroxidation (Halliwell and
Gutteridge, 2007). Thus, it may be presumed that Orn and Hcit
cause lipid peroxidation in cerebellum.
The next step of our investigation was to evaluate the effects of the
classic antioxidants GSH, MEL, TRO, LA, SOD plus CAT and L-NAME on
the lipid peroxidation induced by Orn. In this context, it is well known
that GSH, MEL, TRO and LA are scavengers of the free radicals super-
oxide, hydroxyl and peroxyl, as well as of peroxynitrite. Besides its
scavenging properties, GSH also protects protein bound sulfhydryl
groups and eliminates hydrogen peroxide and lipid peroxide as a co-
factor for the antioxidant enzyme glutathione peroxidase. The effect
of the nitric oxide synthase inhibitor L-NAME was ﬁnally evaluated
in order to speciﬁcally determine the involvement of reactive nitro-
gen species.
We observed that Orn-induced lipid oxidative damage was totally
prevented by the free radical scavengers GSH and MEL, suggesting that
Orn provokes a prooxidant effect on membrane lipids from cerebellum
probably by the hydroxyl and other radicals that are scavenged by
Fig. 4. Effect of antioxidants on ornithine (Orn)-induced lipid peroxidation (thiobarbituric acid-reactive species increase) in rat cerebellum. Cerebellum supernatants were
co-incubated for 1 h at 37 °C with 5 mM Orn and either 1500 μM reduced glutathione (GSH) (A), 1000 μM melatonin (MEL) (B), 7.5 μM trolox (TRO, soluble α-tocopherol) (C),
500 μM Nω-nitro-L-arginine methyl ester (L-NAME) (D) or 100 μM lipoic acid (LA) (E). Values are means ± standard deviation for six independent (animals) experiments
performed in triplicate and are expressed as nmol/mg protein. ***P b 0.001, compared to control; ###P b 0.001, compared to 5 mM Orn (Duncan multiple range test).
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by any of these metabolites, in contrast to hydrogen peroxide produc-
tion, which was signiﬁcantly enhanced by Hcit, it may be presumed
that Orn- and Hcit-elicited oxidative damage through induction of reac-
tive oxygen species generation. Interestingly, hydrogen peroxide gives
rise to the hydroxyl radical by the Fenton reaction (Halliwell and
Gutteridge, 2007).
We also found that GSH concentrations were decreased by Orn and
Hcit, whereas sulfhydryl content was diminished by Orn. It should be
emphasized here that GSH is the major naturally-occurring brainTable 1
Effect of ornithine (Orn) and homocitrulline (Hcit) on the activities of respiratory chain
complexes in rat cerebellum.
Control 0.1 mM 0.5 mM 1.0 mM 5.0 mM
I–III
Orn 6.72 ± 1.82 7.23 ± 1.6 6.97 ± 2.04 7.33 ± 1.6 7.25 ± 1.42
Hcit 7.95 ± 1.06 6.96 ± 2.91 5.81 ± 1.58 5.61 ± 1.49 7.1 ± 2.01
II
Orn 4.82 ± 1.19 6.16 ± 0.75 6.18 ± 2.01 6.57 ± 1.73 6.21 ± 1.69
Hcit 6.59 ± 1.22 5.99 ± 1.39 6.23 ± 1.48 6.11 ± 1.47 6.11 ± 1.05
II–III
Orn 22.3 ± 4.8 23.4 ± 5.14 22.7 ± 5.43 23.4 ± 5.69 23.5 ± 4.54
Hcit 21.6 ± 3.85 21.9 ± 4.42 22.6 ± 5.34 23.2 ± 7.35 21.7 ± 4.52
IV
Orn 10.9 ± 1.19 10 ± 2.84 10.3 ± 2.62 10.8 ± 2.91 12 ± 2.67
Hcit 14.5 ± 3.43 11.1 ± 2.78 12.4 ± 1.01 10.5 ± 2.63 13.8 ± 2.35
Values aremean ± standard deviation for four to six independent (animals) experiments
per group. The activities of complexes I–IV are expressed as nmol/min/mg protein. No
signiﬁcant differences between groups were detected (One-way ANOVA).antioxidant (Halliwell and Gutteridge, 2007) and that sulfhydryl
groups, which are found as protein-bound groups and as components
of small molecules, represent an important redox antioxidant pool in
the cellular defenses against oxidative stress (Hansen and Winther,
2009; Thomas et al., 1995; Requejo et al., 2010). Taken together, these
ﬁndings indicate that the non-enzymatic antioxidant defenses are
compromised by these metabolites in the cerebellum.
Since oxidative stress results from an imbalance between the total
antioxidant defenses and the reactive species generated in a tissue
(Halliwell and Gutteridge, 2007), our present data strongly indicate
that Orn and Hcit, the major amino acids accumulating in HHH syn-
drome, induce this deleterious cell condition in rat cerebellum. It
should be also emphasized that the CNS has low cerebral antioxidant
defenses compared with other tissues (Halliwell and Gutteridge,
2007), a fact that makes this tissue more vulnerable to increased reac-
tive species.
With respect to the parameters of energy metabolism, Orn and
Hcit did not change the activities of the respiratory chain complexes
I–IV, α-ketoglutarate dehydrogenase complex, creatine kinase and
Na+,K+-ATPase. In contrast, we observed that Orn and Hcit decreased
aconitase activity. In this particular, it is well reported that aconitase
is a sensitive target of reactive oxygen species representing a param-
eter of oxidative stress (Liang et al., 2000; Patel et al., 1996; Tretter
and Adam-Vizi, 2000; Tretter et al., 2005; Myers et al., 2010). In
fact, Orn-induced decrease of aconitase activity was totally prevented
by the antioxidant GSH, reinforcing the other ﬁndings demonstrating
that the effects caused by Orn are mediated by reactive oxygen spe-
cies. Furthermore, considering that aconitase is susceptible to oxida-
tive inactivation, particularly by superoxide, resulting in the release
of a labile Fe from its catalytic 4Fe–4S center and hydrogen peroxide
Fig. 5. Effect of ornithine (Orn) and homocitrulline (Hcit) on aconitase activity in rat cerebellum. Mitochondrial fractions were incubated for 30 min at 37 °C with Orn or Hcit (0.5–
5 mM) (A). In some experiments, 5 mM Orn was co-incubated with 1500 μM reduced glutathione (GSH), 7.5 μM trolox (TRO, soluble α-tocopherol) or 1000 μMmelatonin (MEL)
(B). Values are means ± standard deviation for six independent experiments performed in triplicate and expressed as μmol/ min/ mg protein. *P b 0.05, **P b 0.01, compared to
controls; #P b 0.05, compared to 5 mM Orn (Duncan multiple range test).
167Â. Zanatta et al. / Life Sciences 93 (2013) 161–168formation (Vasquez-Vivar et al., 2000; Myers et al., 2010), it is pre-
sumed that Hcit-induced inhibition of aconitase may be related to
the increase of hydrogen peroxide. However, it should be noted that
other reactive species are capable of inactivating aconitase (Gardner
et al., 1997). Therefore, our ﬁndings demonstrating that Orn inhibited
aconitase activity, but did not alter hydrogen peroxide levels, indicate
that other reactive species are involved in Orn-induced aconitase
inhibition.
Previous results obtained in cerebral cortex of rats showed a dual
mechanism of brain damage caused by Orn and Hcit. It was revealed
that these metabolites disturb energy homeostasis, by inhibiting the
activities of respiratory chain complexes, CK and α-ketoglutarate de-
hydrogenase, as well as redox homeostasis, by causing protein and
lipid oxidative damage and decreasing the antioxidant defenses
(Amaral et al., 2009; Viegas et al., 2009, 2011). Our present results,
demonstrating that oxidative stress is induced by Orn and Hcit in cer-
ebellum with no disruption of energy dysfunction, indicate that oxi-
dative damage and disturbance of antioxidant defenses probably
represent the major mechanism of injury in this cerebral structure.
At the present we cannot determine the pathophysiological rele-
vance of the present data since to our knowledge concentrations of Orn
and Hcit in cerebellum or other brain structures were never measured
in HHH syndrome. On the other hand, it should be considered that
blood Orn concentrations may achieve 1 mM in affected patients and
that some of our positive signiﬁcant results were obtained at these
doses (Palmieri, 2008; Valle and Simell 2001). Although our present re-
sults better mimic an acute effect of themajormetabolites accumulating
in HHH syndrome, we cannot rule out that a persistent effect of elevated
concentrations of Orn andHcitmay also induce a disruption of redox ho-
meostasis in this disorder. Therefore, in case the present in vitro results
are conﬁrmed in vivo in animal studies and in affected patients, it may
be presumed that this pathomechanismmay contribute to the cerebellar
atrophy characteristic of HHH syndrome. It should be also noted
that during episodes of metabolic decompensation characterized byencephalopathy and intense proteolysis, much higher concentrations of
these amino acids take place therefore facilitating CNS injury (Camacho
et al., 1999).Conclusion
In conclusion, this is the ﬁrst report showing that oxidative stress is
elicited by Orn and Hcit in cerebellum of young rats. It is therefore
presumed that, besides hyperammonemia, themajormetabolites accu-
mulating in HHH syndrome may contribute to the cerebellum abnor-
malities and symptoms found in patients affected by this disease
possibly through reactive oxygen species attack. Furthermore, it is con-
ceivable that a protein restricted diet with high caloric intake that re-
duce the risk of increased elevation of brain Orn and Hcit during
catabolic states allied to the administration of antioxidants may repre-
sent a potential adjuvant therapy for patients affected by HHH
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